Case number 1:18-cv-01071
Genzyme Corporation et al v. Gland Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 23, 2020 | 16 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) |
| Jan 23, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (amf) |
| Jan 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re D.I. [16] Proposed Consent Judgment - filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC. So Ordered by Judge Kent A. Jordan on 1/23/2020. (amf) |
| Jan 14, 2020 | 15 | Status Report (2) Docket Text: STATUS REPORT by Gland Pharma Limited. (Gattuso, Dominick) |
| Dec 19, 2019 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME To File Status Report to December 23, 2019 - filed by Gland Pharma Limited. (Gattuso, Dominick) |
| Jan 9, 2019 | N/A | SO ORDERED (0) |
| Jan 2, 2019 | 13 | Stipulation (5) Docket Text: STIPULATION to Stay Pending Appeal by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) |
| Dec 6, 2018 | N/A | SO ORDERED (0) |
| Dec 5, 2018 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to January 7, 2019 - filed by Gland Pharma Limited. (Gattuso, Dominick) |
| Nov 14, 2018 | N/A | SO ORDERED (0) |
| Nov 14, 2018 | N/A | Set/Reset Answer Deadline(s) (0) Docket Text: Set/Reset Answer Deadlines: Gland Pharma Limited answer due 12/5/2018. (ceg) |
| Nov 13, 2018 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendant's Time to Respond to Plaintiffs' Complaint for Patent Infringement to December 5, 2018 - filed by Gland Pharma Limited. (Gattuso, Dominick) |
| Oct 30, 2018 | 10 | Stipulation to EXTEND Time (2) Docket Text: Second STIPULATION TO EXTEND TIME to Respond to Complaint to November 14, 2018 - filed by Gland Pharma Limited. (Gattuso, Dominick) |
| Oct 17, 2018 | N/A | SO ORDERED (0) |
| Oct 15, 2018 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to October 31, 2018 - filed by Gland Pharma Limited. (Gattuso, Dominick) |
| Aug 27, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Sanofi-Aventis U.S. LLC, Genzyme Corporation: For Gland Pharma Limited waiver sent on 7/19/2018, answer due 10/17/2018. (Bove, Jeffrey) |
| Aug 24, 2018 | 7 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Gland Pharma Limited on 7/19/2018 by Genzyme Corporation, Sanofi-Aventis U.S. LLC. Waiver of Service due by 9/17/2018. (Bove, Jeffrey) |
| Aug 6, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (rjb) |
| Aug 6, 2018 | 6 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by the Honorable D. Brooks Smith, Chief Judge of the United States Court of Appeals for the Third Circuit, on 8/6/18. (rjb) |
| Jul 19, 2018 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (ceg) |
| Jul 19, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) |
| Jul 19, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE42,152 E; US 7,897,590 B2; US 6,987,102 B2. (ceg) |
| Jul 19, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/7/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 12/7/2020. (ceg) |
| Jul 19, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Jul 19, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 19, 2018 | 1 | Exhibit D (20) |
| Jul 19, 2018 | 1 | Exhibit C (18) |
| Jul 19, 2018 | 1 | Exhibit B (14) |
| Jul 19, 2018 | 1 | Exhibit A (5) |
| Jul 19, 2018 | 1 | Complaint (18) |
| Jul 19, 2018 | 1 | Main Document (18) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Gland Pharma Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422639.) - filed by Sanofi-Aventis U.S. LLC, Genzyme Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(ceg) |
| Jul 19, 2018 | 1 | Complaint* (1) |
